dad5gne vaccine

Vaccineexperimental

Clinical trial activity

1 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0

Earliest trial started May 1, 2015 (NCT02455479)

Timeline

2010s

  1. Jan 1, 2015

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

  • cocaineImmunity, active

    cocaine immunity, active

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • dad5gne vaccine

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02455479Phase 1May 1, 2015Cornell University
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Cornell UniversityAcademic/Hospital1112015
1 organizations
Page 1 / 1